Skip to content

Septerna, Inc. SEPN Occupancy and Related Charges

Occupancy and Related Charges at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$6.5M+12.1%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s occupancy and related charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s occupancy and related charges?
Septerna, Inc. (SEPN) reported occupancy and related charges of $566K in Q1 2026.
How has Septerna, Inc.'s occupancy and related charges changed year-over-year?
Septerna, Inc.'s occupancy and related charges increased by 9.7% year-over-year, from $516K to $566K.
What does occupancy and related charges mean?
This metric captures the cash outflow associated with the rental of facilities or equipment necessary for business operations. It reflects the recurring cost of maintaining physical infrastructure required for laboratory and administrative functions. Tracking this helps assess the fixed cost burden and operational efficiency of the company's physical footprint.